%D9%81%D8%A7%D9%84%D8%A7%D8%B3%D9%8A%D9%83%D9%84%D9%88%D9%81%D9%8A%D8%B1%D9%88%D8%A7%D9%84%D8%A7%D8%B3%DB%8C%DA%A9%D9%84%D9%88%D9%88%DB%8C%D8%B1Category:ValaciclovirFalaciclofirValaciclovirValaciclovirValaciclovir%D9%88%D8%A7%D9%84%D8%A7%D8%B3%DB%8C%DA%A9%D9%84%D9%88%D9%88%DB%8C%D8%B1ValasikloviiriValaciclovirValaciclovir%E3%83%90%E3%83%A9%E3%82%B7%E3%82%AF%E3%83%AD%E3%83%93%E3%83%AB%E0%B4%B5%E0%B4%BE%E0%B4%B2%E0%B4%B8%E0%B4%BF%E0%B4%95%E0%B5%8D%E0%B4%B2%E0%B5%8B%E0%B4%B5%E0%B4%BF%E0%B5%BCValaciclovir%D0%92%D0%B0%D0%BB%D0%B0%D1%86%D0%B8%D0%BA%D0%BB%D0%BE%D0%B2%D0%B8%D1%80ValaciklovirValaciklovirValaciklovirValaciklovir%E0%B8%A7%E0%B8%B2%E0%B8%A5%E0%B8%B2%E0%B9%84%E0%B8%8B%E0%B9%82%E0%B8%84%E0%B8%A5%E0%B9%80%E0%B8%A7%E0%B8%B5%E0%B8%A2%E0%B8%A3%E0%B9%8C%D0%92%D0%B0%D0%BB%D0%B0%D1%86%D0%B8%D0%BA%D0%BB%D0%BE%D0%B2%D1%96%D1%80ValaciclovirQ418594%E4%BC%90%E6%98%94%E6%B4%9B%E9%9F%A6
about
P3781
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerHSV-tk and XRT and Chemotherapy for Newly Diagnosed GBMA Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsBortezomib and Rituximab for Patients With Waldenstrom's MacroglobulinemiaDose-finding Study of ASP2151 in Subjects With Herpes ZosterA Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesResearch Study of Bipolar Mood Symptoms and Cognitive ProblemsRandomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2Cytomegalovirus Control in Critical CareEvaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney TransplantationScandinavian Bell's Palsy StudyStudy Comparing the Safety of ASP2151 to Valacyclovir and Placebo in Healthy VolunteersCan Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryEarly Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral IsotretinoinTo Rescue Cognition With ValaciclovirRandomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) KeratitisHSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBMEpstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control TrialA Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting ConditionA Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed ConditionReduction of Postherpetic Neuralgia in Herpes ZosterCan Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?Valacyclovir 1000 mg Tablet Under Fasting ConditionsValacyclovir 1000 mg Tablet Under Fed ConditionsBioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed ConditionBioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting ConditionsIn UTERO Treatment of Cytomegalovirus Congenital Infection With ValacyclovirHerpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis CIn Utero Treatment of Cytomegalovirus congénitale Infection With ValacyclovirValacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected PersonsValaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation PatientsSafety and Efficacy Comparator Trial of a New Drug Against Genital HerpesZoster Eye Disease StudyA Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase SchizophreniaPhase III Study of ASP2151 in Herpes Zoster PatientsNeoadjuvant GMCI Plus mFOLFIRINOX and Chemoradiation for Non-Metastatic Pancreatic Adenocarcinoma
P4844
A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and salivaLong-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiformeThe effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpesAcute renal injury induced by valacyclovir hydrochloride: A case reportThe antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipesEffects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trialValacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy.Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: A randomized clinical trial of dosing regimens.Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage ManagementAssay and stability-indicating micellar electrokinetic chromatography method for the simultaneous determination of valacyclovir, acyclovir and their major impurity guanine in pharmaceutical formulations.Antiviral drug valacyclovir treatment combined with a clean feeding system enhances the suppression of salivary gland hypertrophy in laboratory colonies of Glossina pallidipes.Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal functionKinetic Study of the Alkaline Degradation of Oseltamivir Phosphate and Valacyclovir Hydrochloride using Validated Stability Indicating HPLC.Valacyclovir and acyclovir pharmacokinetics in immunocompromised children.Efficacy of Oral Valacyclovir Treatment in a Case with Acute Retinal NecrosisEffect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatmentThe effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers.Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.Neurotoxicity caused by valacyclovir in a patient on hemodialysis.Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits.A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.DNA interaction studies of a copper (II) complex containing an antiviral drug, valacyclovir: the effect of metal center on the mode of binding.Once-daily valacyclovir to reduce the risk of transmission of genital herpes.Methylprednisolone, valacyclovir, or the combination for vestibular neuritis.Valacyclovir in the treatment of acute retinal necrosis.Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trialValacyclovir to expedite the clearance of recurrent herpes gladiatorum.Pediatric uses of valacyclovir, penciclovir and famciclovir.Valacyclovir in the treatment of genital herpes and herpes zoster.Prophylactic valacyclovir to prevent outbreaks of primary herpes gladiatorum at a 28-day wrestling camp.Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi.Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
P921
Q61864892-02DC0FD5-8423-4D28-BAF4-0403C326FD9DQ61907484-72D2C1AE-5923-438B-AFCF-FC0EE86128CCQ61915531-0AB81959-CB3E-4C77-BFAB-BA62150BAB55Q61917916-206F4623-39EA-413E-9A77-DBD8E897F643Q61918306-DD445217-8A7C-4177-8B84-2D55023005A9Q61918446-3B190C1A-EA24-43B1-A483-5B5191B4C495Q61921287-4548EDCD-8B96-4F54-9EC1-2619037938CAQ61934880-9274B563-25DB-4BD1-B770-368A0344871DQ61957360-25D45FB1-9D6A-474D-AEA8-C69D02B154E0Q61966959-CB7AC4AC-174B-46BE-87B1-910CEE6ABD9CQ61969545-7AA822D5-F1BD-48F3-858F-A82CCB25C2D6Q61975236-109A4A08-3274-41A9-B800-ABF1A234685DQ61979257-FF88878E-3A9C-4449-8464-4620E86B199FQ61980643-C7687021-3D0C-4473-8DBE-6D42238EE354Q61981449-F9F30FB8-2FFF-4BC5-A5CC-1146AE9CA222Q62811598-2A3A79CB-53AD-4861-9A2B-D4B6D725FA46Q62818553-C63312C0-E7DC-4491-BAA3-A2748F8B200BQ63334043-E810807D-0274-4251-96A0-EA5DB88FC270Q63336071-0122F2A0-3B0B-41BF-A310-D1AC73684043Q63393702-288F63BE-C2F8-4774-8936-647079140693Q63394592-742AA7F7-1FE6-4BE3-B76E-A15C5B7B0532Q63597258-752E3A38-9BA9-4F3D-B9BE-DB52687BAF7CQ63817433-88EA13FB-69F3-4ED2-BB25-8980ACE044B2Q63817435-FE9E3564-566C-413F-BA6B-D3B009640C4AQ63819002-38D7259A-18FC-4E39-B5CA-8E3AEBAD2087Q63829931-CC4AC683-A6FE-4068-86CD-4296D088CDE1Q63830002-B5038B6C-391D-4043-B4F1-03E26B91BE49Q63830011-4C1908CA-7370-4D23-A9D5-AAA63B6BBF2CQ63833752-9A8916B1-8F45-4433-9701-F100D904E57FQ63833755-45704559-30AF-4CC9-9448-49575E7FB3A5Q63834693-032831BE-E0D3-4F9C-94CE-5ADB5721301DQ63834727-B405A1FE-0D75-4588-B1ED-8DA886C6C546Q63838439-195E00FB-EAA2-4E2B-9576-3A4C464BD059Q63838973-68CA215D-A625-4665-A453-9594F882E1CBQ63843765-8A22D88E-B320-4D96-BEC3-434DEB611EF5Q64029729-9CDABD3A-BCCB-4BF1-A961-11EF05CE0CEAQ64189739-9239A75E-DE98-40E0-A6F2-044532AD0BF7Q64351285-2B41A51B-C0EE-4CE2-A8D7-141E459951FAQ64353341-F89665E4-7FF3-4190-B8BE-A6C90545EF30Q64396005-12D4DDC1-AB44-4510-A6E4-407FBD329A4B
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Valaciclovir
@de
Valaciclovir
@es
Valaciclovir
@it
Valaciclovir
@nl
Valaciclovir
@pt
Valaciclovir
@pt-br
Valaciclovir
@vi
Valaciklovir
@sh
Valaciklovir
@sl
Valaciklovir
@sr
type
label
Valaciclovir
@de
Valaciclovir
@es
Valaciclovir
@it
Valaciclovir
@nl
Valaciclovir
@pt
Valaciclovir
@pt-br
Valaciclovir
@vi
Valaciklovir
@sh
Valaciklovir
@sl
Valaciklovir
@sr
altLabel
124832-26-4
@fr
256U87 HCl
@cy
256U87 HCl
@en
C13H20N6O4
@fr
L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine
@cy
L-Valine ester with 9-((2-hydroxyethoxy)methyl)guanine
@en
L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester
@cy
L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester
@en
Valaciclovir
@en
Valaciclovirum
@en
prefLabel
Valaciclovir
@de
Valaciclovir
@es
Valaciclovir
@it
Valaciclovir
@nl
Valaciclovir
@pt
Valaciclovir
@pt-br
Valaciclovir
@vi
Valaciklovir
@sh
Valaciklovir
@sl
Valaciklovir
@sr